Michele Colucci, Founder + Managing Partner, is a lawyer, investor, serial entrepreneur, and philanthropist. She has authored six patents in the technology space and founded companies in the legal, technology, retail, and entertainment spaces. Michele’s extensive experience operating in highly regulated verticals has focused on issues from management to legal (employment, corporate, International, litigation, torts, negotiations, business strategy, and marketing). Her most recent company focused on the application of big data and artificial intelligence in legal technology. She has worked at law firms including Hughes Hubbard & Reed, run her own media production company, owned and operated a chain of retail stores in the political space, run a political fundraising venue, and founded a legal technology company.

Currently, Michele serves on the Boards of Directors Nephrosant, Optina Diagnostics, Prime Genomics, and Delphi Diagnostics and previously the Global Indemnity Group. She is also an Advisor to eHealth Analytics (a digital health startup) and Quantellia (a platform powering decision-based analytics through artificial intelligence). She has blogged for the Huffington on female entrepreneurship and is an award-winning expert on E-Local. She served as a guest lecturer and mentor at Stanford University’s School of Engineering focused on Global Marketing and Entrepreneurship and has lectured at USF in marketing and at USC’s Gould School of Law.